We put a call out to our generous employees, who donated more than $1500 (with 100% participation! H+C is matching the donations, bringing the total to $3200. Thank you Frontline Foods for all you are doing for restaurants and healthcare workers! frontlinefoods.org/santa-rosasono…

Thank you BARDA Our Lady of the Lake Health! #COVID19 #coronavirus #COVID #Covid_19 #CoronaVirusUpdate #Covid19Research #HighRiskCovid19 #sepsis

Today we announced an agreement with Dyno Therapeutics, Inc. to develop next-gen AAV vectors for muscle diseases. With our leadership in rare diseases, we're thrilled to invest in additional innovative approaches to build our #genetherapy engine. Learn more: bit.ly/2xW5hDU SRPT

Cheers to H+C client argenx for announcing results of their first Phase 3 clinical trial. 👏 Positive results showed significant improvements in certain patients with the rare muscle disease #myastheniagravis statnews.com/2020/05/26/arg…

$SRPT gene therapy for limb-girdle disease shows improved muscle function after one year statnews.com/2020/06/08/sar…

Data on Sarepta’s experimental gene therapy for a rare type of muscular dystrophy delivered another early-stage win trib.al/oy0ky6b

Progress.

Check out this roundup by Medical Design & Outsourcing + MassDevice highlighting an impressive roster of MedTech Innovator companies and H+C clients — @GTMedTech, Imperative_Care, PhotoniCare, Aerin Medical, & CloudCath — as some of the most exciting and promising #MedDevice startups in 2020!

Excited for MedtechWomen to tackle this important conversation w/MedTechColor. The time to invoke this change in #healthcare is certainly long overdue, & I’m proud to see industry groups run by women & POC create a space to 🗣️ about it through events like this. Count me in!

NeuroPace has raised $67 million to expand use of neurostimulation technology for certain epilepsy patients wsj.com/articles/neuro…

Sarah McBride, a Democrat who won a seat in the Delaware Senate, will be the first transgender state senator in the U.S. She is one of several candidates who broke barriers on Tuesday. nyti.ms/38fvm0x

GT Medical Technologies Raised $16M In Funding To Expand Brain Tumor Therapy IrmaRaste ✨ InfluenceThroughStorytelling™ #cancer #braintumor #funding #VentureCapital medtech.pharmaintelligence.informa.com/articles/2020/…

Great story from Twin Cities Business on UroDev Medical's new CEO Matt Monarski and HQ in Minneapolis 👏 Lots to look forward to this year: IntelliFlow study results, FDA clearance submission & fundraising for a Series B to help provide a better option for people who rely on urinary catheters

Can you imagine where healthcare (or any industry) would be without women? Today we celebrate those who #ChoosetoChallenge inequality by standing up to gender bias, creating inclusive workspaces, and recognizing the many achievements of women in all spaces. #IWD2021

“We see this having the potential to be an all-day presbyopia-correcting eye drop,” Visus CEO Ben Bergo told Endpoints News. endpts.com/no-more-squint…

Another biotech looking to bring cell therapy beyond cancer Aurion is trying to cure blindness with a treatment that repairs endothelial cells the cornea. Here's the pitch deck they used to raise $120 million: businessinsider.com/pitch-deck-cel…

manifestation tweet: everyone who retweets this tweet will get tickets to taylor swift’s the eras tour

Heartbroken Santa Clara Swiftie over here. Lover Fest ticket holder, with a standard Verified Fan presale code AND access to Capital One presale. Nothing but this. Two tickets that keep getting error codes because it was leaving a single aisle seat with no option to purchase it.

My first #JPM23 since joining Sarepta. Excited for the year ahead!

In the biggest bet on AI for drug discovery and development yet, Xaira Therapeutics has raised over $1 billion from ARCH, Foresite and others, Andrew Dunn and I exclusively report for Endpoints News. endpts.com/in-biggest-eve…